n-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane has been researched along with 3,4-methylenedioxyamphetamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clare, BW | 1 |
Foltz, RL; Lim, HK | 1 |
Clark, CR; Ravis, WR; Valaer, AK | 1 |
Glennon, RA; Misenheimer, BR | 1 |
Nakahara, Y; Shimamine, M; Takahashi, K | 1 |
Brzozowski, D; Clark, CR; Ravis, WR; Valaer, AK | 1 |
Goda, Y; Kawamura, M; Kikura-Hanajiri, R; Miyajima, A; Sunouchi, M | 1 |
Inoue, H; Iwata, YT; Kanamori, T; Kuwayama, K; Mikuma, T; Miyaguchi, H; Tsujikawa, K | 1 |
8 other study(ies) available for n-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane and 3,4-methylenedioxyamphetamine
Article | Year |
---|---|
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |
In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Animals; Brain Chemistry; Injections, Subcutaneous; Liver; Male; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1991 |
Liquid chromatographic properties and aqueous solution stability of N-hydroxy-3,4-methylenedioxyamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, Liquid; Drug Stability; Hallucinogens; Hydrogen-Ion Concentration; Solutions | 1990 |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1989 |
[Studies on the identification of psychotropic substances. IX. Preparation and various analytical data of reference standard of new psychotropic substances, N-ethyl methylenedioxyamphetamine, N-hydroxy methylenedioxyamphetamine, mecloqualone, 4-methylamin
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Morpholines; Oxazoles; Phenmetrazine; Psychotropic Drugs; Quinazolines; Spectrophotometry | 1993 |
The pharmacokinetics and liver metabolism of N-hydroxy-3,4-methylenedioxyamphetamine (N-OH MDA) in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biotransformation; Half-Life; In Vitro Techniques; Liver; Male; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley | 1994 |
Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, Liquid; Designer Drugs; Forensic Toxicology; Hair; Hallucinogens; Male; Rats; Tandem Mass Spectrometry | 2010 |
Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Animals; Hydrolysis; Hydroxylation; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2011 |